NASDAQ:NDRA - ENDRA Life Sciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.13 -0.16 (-4.86 %)
(As of 03/22/2019 02:07 PM ET)
Previous Close$3.29
Today's Range$3.04 - $3.16
52-Week Range$1.44 - $5.75
Volume1,224 shs
Average Volume618,685 shs
Market Capitalization$20.75 million
P/E RatioN/A
Dividend YieldN/A
Beta0.5
ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging technologies, such as CT, MRI, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease or internal bleeding. It also offers the Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.

Receive NDRA News and Ratings via Email

Sign-up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NDRA
CUSIPN/A
Phone734-335-0468

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$10,000.00
Book Value$0.94 per share

Profitability

Net Income$-9,800,000.00

Miscellaneous

EmployeesN/A
Market Cap$20.75 million
Next Earnings Date5/21/2019 (Estimated)
OptionableNot Optionable

ENDRA Life Sciences (NASDAQ:NDRA) Frequently Asked Questions

What is ENDRA Life Sciences' stock symbol?

ENDRA Life Sciences trades on the NASDAQ under the ticker symbol "NDRA."

How were ENDRA Life Sciences' earnings last quarter?

ENDRA Life Sciences Inc (NASDAQ:NDRA) posted its earnings results on Monday, March, 11th. The company reported ($0.28) earnings per share for the quarter. View ENDRA Life Sciences' Earnings History.

When is ENDRA Life Sciences' next earnings date?

ENDRA Life Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, May 21st 2019. View Earnings Estimates for ENDRA Life Sciences.

Has ENDRA Life Sciences been receiving favorable news coverage?

News stories about NDRA stock have trended negative on Friday, according to InfoTrie Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. ENDRA Life Sciences earned a media sentiment score of -2.7 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future.

Who are some of ENDRA Life Sciences' key competitors?

What other stocks do shareholders of ENDRA Life Sciences own?

Who are ENDRA Life Sciences' key executives?

ENDRA Life Sciences' management team includes the folowing people:
  • Mr. Francois Michelon, Chairman & CEO (Age 53)
  • Mr. David R. Wells, Chief Financial Officer (Age 57)
  • Mr. Michael Thornton, Chief Technology Officer (Age 51)
  • Dr. Jonathan Behr Ph.D., Co-Founder

When did ENDRA Life Sciences IPO?

(NDRA) raised $10 million in an initial public offering (IPO) on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities acted as the underwriters for the IPO.

Who are ENDRA Life Sciences' major shareholders?

ENDRA Life Sciences' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include ICM Asset Management Inc. WA (10.12%), Geode Capital Management LLC (0.72%), Geode Capital Management LLC (0.72%), Creative Planning (0.53%) and National Asset Management Inc. (0.35%). View Institutional Ownership Trends for ENDRA Life Sciences.

Which institutional investors are buying ENDRA Life Sciences stock?

NDRA stock was bought by a variety of institutional investors in the last quarter, including ICM Asset Management Inc. WA, Geode Capital Management LLC, Geode Capital Management LLC, Creative Planning and National Asset Management Inc.. View Insider Buying and Selling for ENDRA Life Sciences.

How do I buy shares of ENDRA Life Sciences?

Shares of NDRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ENDRA Life Sciences' stock price today?

One share of NDRA stock can currently be purchased for approximately $3.13.

How big of a company is ENDRA Life Sciences?

ENDRA Life Sciences has a market capitalization of $20.75 million and generates $10,000.00 in revenue each year.

What is ENDRA Life Sciences' official website?

The official website for ENDRA Life Sciences is http://www.endrainc.com.

How can I contact ENDRA Life Sciences?

ENDRA Life Sciences' mailing address is 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105. The company can be reached via phone at 734-335-0468 or via email at [email protected]


MarketBeat Community Rating for ENDRA Life Sciences (NASDAQ NDRA)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  139 (Vote Underperform)
Total Votes:  256
MarketBeat's community ratings are surveys of what our community members think about ENDRA Life Sciences and other stocks. Vote "Outperform" if you believe NDRA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NDRA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/22/2019 by MarketBeat.com Staff

Featured Article: Economic Reports

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel